Prostate

Latest stories

  • in Health care

    Janssen gets European Commission nod for AKEEGA to treat metastatic castration resistant prostate cancer with BRCA1/2 mutations

    by

    Beerse: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that the European Commission (EC) has granted marketing authorisation for AKEEGA (niraparib and abiraterone acetate [AA]), in the form of a dual action tablet (DAT), given with prednisone or prednisolone, for the treatment of adults with metastatic castration-resistant prostate cancer (mCRPC) and BRCA1/2 mutations (germline […] More

  • in Health care

    Unhealthy diet may heighten risk of prostate cancer: Study

    by

    Adhering to healthy diets seems to have no effect on prostate cancer risk, but following an unhealthy diet might increase the risk of developing aggressive prostate cancer, according to a study published in BJU International. The study assessed the diets of 15,296 men recruited in Spain in from 1992-1996. Among these men, 609 prostate cancer […] More

  • in Health care

    Vitamin D may play a role in prostate cancer disparities: Study

    by

    New research from Cedars-Sinai Cancer suggests that vitamin D deficiency could be the reason African American men experience more aggressive prostate cancer at a younger age compared with European American men. The multi-institutional study, published today in Cancer Research Communications, a journal of the American Association for Cancer Research (AACR), could pave the way for […] More

  • in Health care

    Enlarged Prostate: When Should You Consult A Urologist?

    Enlarged Prostate: When Should You Consult A Urologist?

    by

    Benign prostatic hyperplasia (BPH) or enlarged prostate is a condition in men that can cause bothersome urinary symptoms. The condition can take a toll on their mental health, disrupt sleep, decreased quality of life and cause loss of productivity. However, having enlarged prostate doesn’t make men more likely to get prostate cancer. The prostate is […] More

  • in Health care

    New immunotherapy agent safe and promising against high-risk prostate cancers

    New immunotherapy agent safe and promising against high-risk prostate cancers

    by

    Enoblituzumab, a monoclonal antibody drug works by binding to a protein called B7-H3 that is overexpressed on prostate cancer cells and believed to impede the immune system’s ability to attack cancer cells. The new drug is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to […] More

  • in Health care

    PSMA PET improves decision making for prostate cancer treatment

    by

    Detailed PSMA PET mapping of cancer recurrence in the prostate bed shows that current radiotherapy contouring guidelines-which determine the target areas for treatment-miss a significant number of lesions and may irradiate healthy tissues unnecessarily. In a new study published online by The Journal of Nuclear Medicine, researchers are calling for the redefinition of prostate bed […] More